European Heart Journal Advance Access published online on August 31, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi447
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Sticares Cardiovascular Research Foundation, PO Box 882, 3160 AB Rhoon, The Netherland
* To whom correspondence should be addressed. Aims Appropriate heart failure (HF) care and adequate resourcing require recognition of its clinical, social, and economic importance by the general public besides healthcare authorities and providers. The extent of public awareness in Europe is not known. Methods and results A total of 7958 subjects were randomly selected from nine European countries (minimum 100/group per country). Each completed a 32-question survey on HF covering recognition, impact on health, comparative prevalence and severity, treatment, and costs. Although 86% of respondents had heard of HF, only 3% could correctly identify HF from a description of typical symptoms and signs, 31% correctly identified angina, and 51% identified transient ischaemic attack/stroke. Only 29% thought that HF signs and symptoms indicate a severe condition. Most thought that HF patients should reduce all physical activity and 34% believed HF a normal consequence of ageing. Sixty-seven per cent thought that HF patients live longer than cancer patients. Only 9% believed that HF leads to greater healthcare expenditure than cancer, HIV, or diabetes. Overall, responses were comparable between countries. Conclusion In Europe, community awareness of HF is low. Therefore, the general public is unlikely to demand appropriate measures by healthcare authorities and providers. A better understanding of HF could improve its prevention and management. Strategies to educate the public about HF are needed.
Received May 23, 2005
Revised July 7, 2005
Accepted July 13, 2005
Clinical research
Public awareness of heart failure in Europe: first results from SHAPE
2 University of Glasgow, Glasgow, UK
3 Institut für Herzinfarktforschung, Ludwigshafen am Rhein, Germany
4 Hôpital Jeanne d'Arc, Dommartin-lès-Toul, France
5 Hôpital Beaujon, Clichy, France
6 Hospital Universitario Gregorio Maranon, Madrid, Spain
7 University of Birmingham, Birmingham, UK
8 University Medical Center, Utrecht, The Netherlands
9 Ospedale S. Giovanni-Addolorata, Rome, Italy
10 Karolinska University Hospital, Stockholm, Sweden
11 Romanian Society of Cardiology, Bucharest, Romania
12 Franz-Volhard-Klinik, Berlin, Germany
13 National Institute of Cardiology, Warsaw, Poland
Willem J. Remme, E-mail: w.j.remme{at}sticares.org
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Zannad, N. Agrinier, and F. Alla Heart failure burden and therapy Europace, November 1, 2009; 11(suppl_5): v1 - v9. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Meredith, J. Ostergren, I. Anand, M. Puu, S. D. Solomon, E. L. Michelson, B. Olofsson, C. B. Granger, S. Yusuf, K. Swedberg, et al. Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program J. Am. Coll. Cardiol., December 9, 2008; 52(24): 2000 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Erhardt, M. Komajda, F.D. R. Hobbs, and J. Soler-Soler Cardiologists' awareness and perceptions of guidelines for chronic heart failure. The ADDress your Heart survey Eur J Heart Fail, October 1, 2008; 10(10): 1020 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Quesada, G. Botto, A. Erdogan, M. Kozak, P. Lercher, J. C. Nielsen, O. Piot, R. Ricci, C. Weiss, D. Becker, et al. Managed ventricular pacing vs. conventional dual-chamber pacing for elective replacements: the PreFER MVP study: clinical background, rationale, and design Europace, March 1, 2008; 10(3): 321 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.K. Oh Echocardiography in heart failure: Beyond diagnosis Eur J Echocardiogr, January 1, 2007; 8(1): 4 - 14. [Full Text] [PDF] |
||||



